Adjuvant oophorectomy and tamoxifen treatment in patients with estrogen receptor-positive and HER2/neu over expressive breast cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(3): 160-162. DOI: 10.3969/j.issn.1671-5144.2003.03.008
|
Citation:
|
Adjuvant oophorectomy and tamoxifen treatment in patients with estrogen receptor-positive and HER2/neu over expressive breast cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(3): 160-162. DOI: 10.3969/j.issn.1671-5144.2003.03.008
|
Adjuvant oophorectomy and tamoxifen treatment in patients with estrogen receptor-positive and HER2/neu over expressive breast cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(3): 160-162. DOI: 10.3969/j.issn.1671-5144.2003.03.008
|
Citation:
|
Adjuvant oophorectomy and tamoxifen treatment in patients with estrogen receptor-positive and HER2/neu over expressive breast cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(3): 160-162. DOI: 10.3969/j.issn.1671-5144.2003.03.008
|
DownLoad: